- OptimizeRx dismissed auditor UHY, effective March 25, 2026.
- Grant Thornton was engaged as new independent auditor for fiscal 2026, effective March 26, 2026.
- Audit reports for 2025 and 2024 carried no adverse opinion, disclaimer, or qualification.
- Company previously disclosed a material weakness tied to controls over completeness and accuracy of data from third-party service organizations.
- No disagreements with UHY were reported; material weakness did not trigger a financial statement restatement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001448431-26-000007), on March 30, 2026, and is solely responsible for the information contained therein.
Comments